first glp-1 approval FDA Approves Oral Semaglutide: Weight Loss Pill First Generic of Once-Daily GLP-1

Targets hyperpigmentation, blemishes and wrinkles

For example, in individuals with a 46,XY karyotype and 5-reductase deficiency or 17-hydroxysteroid dehydrogenase deficiency diagnosed at birth, current guidelines support assigning sex in accordance with chromosomal and gonadal sex, as is also recommended for individuals with 46,XX CAH

That doesnt mean MIDI will be sold for that amount, but it does mean venture capitalists (VC) have it valued at that and believe they will eventually sell it for more (and that doesnt always happen)

3) If you are pregnant, breastfeeding, or on any medications, consult a health professional before use